CX1739
跳转到导航
跳转到搜索
| File:CX1739 structure.png | |
| 临床资料 | |
|---|---|
| 其他名称 | CX-1739 |
| 法律规范状态 | |
| 法律规范 |
|
| 识别信息 | |
| |
| CAS号 | 1086377-48-1 check |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| E编码 | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Module:EditAtWikidata第29行Lua错误:attempt to index field 'wikibase' (a nil value) |
| 化学信息 | |
| 化学式 | C13H15N3O3 |
| 摩尔质量 | 261.28 g·mol−1 |
| 3D模型(JSmol) | |
| |
| |
CX1739是一种由Cortex药业(现为RespireRx)开发的研究性新药,目前正在评估其用于治疗多种疾病,例如注意力不足过动症[1]、自闭症[2]、阿片引发的呼吸抑制[3][4]及Module:WikidataLink第216行Lua错误:attempt to index field 'wikibase' (a nil value)。[5]
合成[编辑]
CX1739可由可由苯并呋咱-5-甲酸和N-甲基四氢吡喃-4-胺反应制得。[6]
参考文献[编辑]
- ^ Radin DP, Lippa A, Rana S, Fuller DD, Smith JL, Cerne R, Witkin JM. Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today. Pharmacology, Biochemistry, and Behavior. 2025, 248: 173967. PMC 11849398 可免费查阅. PMID 39894310. doi:10.1016/j.pbb.2025.173967. 已忽略未知参数
|pmc-embargo-date=(帮助) - ^ Silverman J, Oliver C, Karras M, Gastrell P, Crawley J. AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Neuropharmacology. 2013, 64 (1): 268–282. PMC 3445667 可免费查阅. PMID 22801296. doi:10.1016/j.neuropharm.2012.07.013.
- ^ Radin DP, Zhong S, Cerne R, Shoaib M, Witkin JM, Lippa A. Low-Impact Ampakine CX1739 Exerts Pro-Cognitive Effects and Reverses Opiate-Induced Respiratory Depression in Rodents. Future Pharmacology. 2024, 4: 173–187. doi:10.3390/futurepharmacol4010012 可免费查阅.
- ^ Xiao D, Xie F, Xu X, Zhou X. The Impact and Mechanism of Ampakine CX1739 on Protection Against Respiratory Depression in Rats. Future Medicinal Chemistry. 2020, 12 (23): 2093–2104. PMID 33030058. doi:10.4155/fmc-2020-0256.
- ^ Ren J, Ding X, Greer JJ. Ampakines Enhance Weak Endogenous Respiratory Drive and Alleviate Apnea in Perinatal Rats. American Journal of Respiratory and Critical Care Medicine. 2015, 191 (6): 704–710. PMID 25594679. doi:10.1164/rccm.201410-1898OC.
- ^ Xiao, Dian; et al. The impact and mechanism of ampakine CX1739 on protection against respiratory depression in rats. Future Medicinal Chemistry (2020), 12(23), 2093-2104. doi:10.4155/fmc-2020-0256.